Results 141 to 150 of about 782 (172)

Selected markers of ovarian cancer and their relation to targeted therapy (Review). [PDF]

Exp Ther Med
Markowska A, Kojs Z, Twardawa D, Pietras J, Markowska J.   +4 more
europepmc   +1 more source

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy. [PDF]

Nat Commun
Wamba BEN, Mondal T, Freenor V F, Shaheed M, Pang O, Bedinger D, Legembre P, Devel L, Bhatnagar S, Leiserowitz GS, Tushir-Singh J.   +10 more
europepmc   +1 more source

Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. [PDF]

Cancers (Basel)
Sato S, Shoji T, Jo A, Otsuka H, Abe M, Tatsuki S, Chiba Y, Takatori E, Kaido Y, Nagasawa T, Kagabu M, Baba T.   +11 more
europepmc   +1 more source

Symposium «Molecular Mechanism of Human Pathologies» [PDF]

, 2009

core  

Design and Evaluation of ZD06519, a Novel Camptothecin Payload for Antibody Drug Conjugates. [PDF]

Mol Cancer Ther
Petersen ME, Brant MG, Lasalle M, Das S, Duan R, Wong J, Ding T, Wu KJ, Siddappa D, Fang C, Zhang W, Wu AML, Hirkala-Schaefer T, Garnett GAE, Fung V, Yang L, Hernandez Rojas A, Lawn SO, Barnscher SD, Rich JR, Colombo R.   +20 more
europepmc   +1 more source

Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients [PDF]

A Bellasi, A Petley, AJ Hutchison, Albert Fournier, Aurélie Lenglet, B Iorio Di, B Kestenbaum, B Rutkowski, CH Hsu, D Lumlertgul, D Maccubbin, D Müller, DO Young, EAM Gale, EM Slominska, ET Bodor, EW Young, F Karpe, GA Block, GA Block, HA Gillmor, I Six, J Denekamp, J Dragovic, J Vasantha, JA Coladonato, JA Ramirez, JB Kirkland, JB Rottembourg, JR Guyton, JR Smythies, K Katai, K Sampathkumar, K Sampathkumar, KH Beyer, LL Haut, M Knip, M Tonelli, Michel Brazier, MJ Taylor, MR Stratford, N Eto, P Chase, P Delanaye, P Pozzilli, P Rutkowski, Pauline Guffroy, S Mathew, SA Kempson, SC Cheng, SC Schiavi, SK Ganesh, SL Winter, Sophie Liabeuf, TJ Berndt, VS Kamanna, Y Sabbagh, Y Takahashi, Ziad A. Massy   +58 more
core   +1 more source

Antibody-Drug Conjugates: A Start of a New Era in Gynecological Cancers. [PDF]

Curr Oncol
Fasih S, Welch S, Lohmann AE.
europepmc   +1 more source

A translational physiologically-based pharmacokinetic model for MMAE-based antibody-drug conjugates. [PDF]

J Pharmacokinet Pharmacodyn
Chang HP, Shah DK.
europepmc   +1 more source

Characterization of Synthesized Ramucirumab-vcMMAE as a Potential Therapeutic Approach in Ovarian Cancer. [PDF]

ACS Omega
Erdogan D, Ayar Kayali H.
europepmc   +1 more source

Promising new drugs and therapeutic approaches for treatment of ovarian cancer-targeting the hallmarks of cancer. [PDF]

BMC Med
Hillmann J, Maass N, Bauerschlag DO, Flörkemeier I.   +3 more
europepmc   +1 more source